Pia K Muchaal1, Matt Hurst1, Shalini Desai2. 1. Centre for Foodborne, Environmental and Zoonotic Infectious Diseases, Public Health Agency of Canada, Guelph, ON. 2. Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada, Ottawa, ON.
Abstract
BACKGROUND: In 2008, the National Advisory Committee on Immunization recommended routine rotavirus immunizations in healthy Canadian infants. Over the following seven years, eight provinces and two territories introduced the rotavirus vaccine into their publicly funded immunization programs. OBJECTIVE: Assess the burden of rotavirus infections before and after implementation of publicly funded immunization programs. METHODS: We analyzed laboratory-confirmed community cases of rotavirus reported to the National Enteric Surveillance Program and hospitalizations of children younger than three years old from 2007 to 2017 with rotavirus diagnosis-specific ICD-10 codes. Rates of illness were calculated for each province for the two years prior to and after implementation of public funding of the vaccine. The year of implementation was not included to accommodate the uptake period of the vaccine. Age-specific rates were assessed in jurisdictions where five years of data were available the year after the vaccine was publicly funded. The pre-post and difference-in-difference (DID) methodologies were applied to hospital discharge data to evaluate changes between the funding and non-funding jurisdictions. RESULTS: Community cases of laboratory-confirmed rotavirus infection reported to the National Enteric Surveillance Program declined by 54% between 2010 and 2017. Rates of hospital discharges decreased significantly among children in six provinces after the adoption of the rotavirus vaccine. Hospital discharge rates in Alberta, Manitoba, Ontario and Prince Edward Island dropped between 53% and 71%, and by 75% for British Columbia and Saskatchewan. CONCLUSION: Public funding of the rotavirus vaccine appeared to lead to significant reductions in laboratory-confirmed rotavirus cases reported to the National Enteric Surveillance Program and in the rates of rotavirus gastroenteritis-related hospital discharges.
BACKGROUND: In 2008, the National Advisory Committee on Immunization recommended routine rotavirus immunizations in healthy Canadian infants. Over the following seven years, eight provinces and two territories introduced the rotavirus vaccine into their publicly funded immunization programs. OBJECTIVE: Assess the burden of rotavirus infections before and after implementation of publicly funded immunization programs. METHODS: We analyzed laboratory-confirmed community cases of rotavirus reported to the National Enteric Surveillance Program and hospitalizations of children younger than three years old from 2007 to 2017 with rotavirus diagnosis-specific ICD-10 codes. Rates of illness were calculated for each province for the two years prior to and after implementation of public funding of the vaccine. The year of implementation was not included to accommodate the uptake period of the vaccine. Age-specific rates were assessed in jurisdictions where five years of data were available the year after the vaccine was publicly funded. The pre-post and difference-in-difference (DID) methodologies were applied to hospital discharge data to evaluate changes between the funding and non-funding jurisdictions. RESULTS: Community cases of laboratory-confirmed rotavirus infection reported to the National Enteric Surveillance Program declined by 54% between 2010 and 2017. Rates of hospital discharges decreased significantly among children in six provinces after the adoption of the rotavirus vaccine. Hospital discharge rates in Alberta, Manitoba, Ontario and Prince Edward Island dropped between 53% and 71%, and by 75% for British Columbia and Saskatchewan. CONCLUSION: Public funding of the rotavirus vaccine appeared to lead to significant reductions in laboratory-confirmed rotavirus cases reported to the National Enteric Surveillance Program and in the rates of rotavirus gastroenteritis-related hospital discharges.
Authors: M Kate Thomas; Regan Murray; Logan Flockhart; Katarina Pintar; Frank Pollari; Aamir Fazil; Andrea Nesbitt; Barbara Marshall Journal: Foodborne Pathog Dis Date: 2013-05-09 Impact factor: 3.171
Authors: Catherine A Panozzo; Sylvia Becker-Dreps; Virginia Pate; David J Weber; Michele Jonsson Funk; Til Stürmer; M Alan Brookhart Journal: Am J Epidemiol Date: 2014-02-26 Impact factor: 4.897
Authors: Fred Zepp; Ulrich Heininger; Jussi Mertsola; Ewa Bernatowska; Nicole Guiso; John Roord; Alberto E Tozzi; Pierre Van Damme Journal: Lancet Infect Dis Date: 2011-05-18 Impact factor: 25.071
Authors: Sarah E Wilson; Laura C Rosella; Jun Wang; Nicole Le Saux; Natasha S Crowcroft; Tara Harris; Shelly Bolotin; Shelley L Deeks Journal: PLoS One Date: 2016-05-11 Impact factor: 3.240
Authors: Sarah E Wilson; Hannah Chung; Kevin L Schwartz; Astrid Guttmann; Shelley L Deeks; Jeffrey C Kwong; Natasha S Crowcroft; Laura Wing; Karen Tu Journal: PLoS One Date: 2018-02-14 Impact factor: 3.240